We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $579M
1-Year Est. Return 94.36%
This Fund
S&P 500
This Quarter Est. Return
+27.59%
1 Year Est. Return
+94.36%
3 Year Est. Return
+196.81%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$592M
AUM Growth
+$78.5M
Cap. Flow
+$48.3M
Cap. Flow %
8.16%
Top 10 Hldgs %
62.58%
Holding
88
New
16
Increased
4
Reduced
1
Closed
7

Top Buys

1
FNCH
Finch Therapeutics Group, Inc. Common Stock
FNCH
+$13.8M
2
ISLE
Isleworth Healthcare Acquisition Corporation Common stock
ISLE
+$9.66M
3
FLNA
Filana Therapeutics
FLNA
+$8.48M
4
CNST
Constellation Pharmaceuticals, Inc.
CNST
+$5.53M
5
GBT
Global Blood Therapeutics, Inc.
GBT
+$4.6M

Top Sells

1
TGTX icon
TG Therapeutics
TGTX
+$3.9M
2
IDN icon
Intellicheck
IDN
+$2.99M
3
EOSEW
Eos Energy Enterprises Warrant
EOSEW
+$2.08M
4
HCARU
Healthcare Services Acquisition Corporation Unit
HCARU
+$1.53M
5
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
+$1.13M

Sector Composition

1 Healthcare 23.53%
2 Industrials 13.57%
3 Consumer Discretionary 12.6%
4 Materials 9.11%
5 Financials 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GLD icon
1
SPDR Gold Trust
GLD
$129B
$76M 12.83%
475,000
– –
LIN icon
2
Linde
LIN
$241B
$54M 9.11%
192,627
– –
DRRX
3
DELISTED
DURECT Corp
DRRX
$52.3M 8.83%
2,641,466
– –
BC icon
4
Brunswick
BC
$5.33B
$47.7M 8.05%
500,000
– –
IVAC
5
DELISTED
Intevac Inc
IVAC
$35.4M 5.97%
4,949,355
– –
INVE icon
6
Identive
INVE
$67.9M
$25.2M 4.25%
2,196,389
– –
OPTU
7
Optimum Communications Inc
OPTU
$348M
$22.9M 3.86%
703,600
+100,000
+17% +$3.48M
FLNA
8
Filana Therapeutics
FLNA
$52.2M
$22.5M 3.79%
500,000
+215,686
+76% +$8.48M
LIQT icon
9
LiqTech
LIQT
$22.4M
$17.5M 2.95%
269,806
– –
IDN icon
10
Intellicheck
IDN
$75.9M
$17.4M 2.93%
2,073,583
-255,095
-11% -$2.99M
THO icon
11
Thor Industries
THO
$4.03B
$14.8M 2.5%
109,753
– –
SPGI icon
12
S&P Global
SPGI
$135B
$14.1M 2.38%
40,000
– –
CDXS icon
13
Codexis
CDXS
$196M
$13.3M 2.24%
579,116
– –
FNCH
14
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$13.1M 2.21%
+27,014
New +$13.8M
MRNS
15
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$12.8M 2.17%
829,910
+117,410
+16% +$1.7M
SHLX
16
DELISTED
Shell Midstream Partners, L.P.
SHLX
$12.2M 2.06%
913,347
– –
GRA
17
DELISTED
W.R. Grace & Co.
GRA
$12M 2.03%
200,934
– –
LSXMK
18
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$10.4M 1.76%
305,187
– –
ISLE
19
DELISTED
Isleworth Healthcare Acquisition Corporation Common stock
ISLE
$9.69M 1.64%
+1,000,000
New +$9.66M
RPRX icon
20
Royalty Pharma
RPRX
$25.9B
$8.72M 1.47%
200,000
– –
FATE icon
21
Fate Therapeutics
FATE
$318M
$8.24M 1.39%
100,000
– –
NS
22
DELISTED
NuStar Energy L.P.
NS
$7.44M 1.26%
435,500
– –
BX icon
23
Blackstone
BX
$158B
$5.96M 1.01%
80,000
– –
DNTH icon
24
Dianthus Therapeutics
DNTH
$5.21B
$5.14M 0.87%
27,150
– –
DUOT icon
25
Duos Technologies
DUOT
$266M
$4.95M 0.84%
453,616
– –
1
2 3 4

Similar funds

BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
LRIA
Leonard Rickey Investment Advisors Yakima, Washington $578M AUM 16.23% 1-Year Est. Return
WCCM
Webs Creek Capital Management Dallas, Texas $578M AUM 79.84% 1-Year Est. Return
MIOT
Massachusetts Institute of Technology Cambridge, Massachusetts $577M AUM 8.5% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
GCM
Gibraltar Capital Management Tulsa, Oklahoma $581M AUM 18.65% 1-Year Est. Return
KNW
Kesler Norman & Wride Ogden, Utah $581M AUM 17.6% 1-Year Est. Return